Molecular Partners AG - Special Call Transcript
Good morning, everyone, and welcome to the Molecular Partners' 2020 Research and Development Day, Unlock and Expand: Custom-Built Biology for Patients. My name is Seth Lewis, Senior Vice President of Investor Relations and Communications. And we're pleased to have you here joining us today as members of senior management and invited guests will provide an update not only on the clinical and research progress of the past year but also the outlook from 2021 and beyond.
As a matter of housekeeping, I would like to inform you all that management will be making certain forward-looking statements today and that this has been broadcast on December 17, 2020. Please refer to our website for our latest corporate updates, should anything have changed since the date of this recording. We also issued a press release this morning, where additional updates were provided, many of which will be covered in today's discussion, but please refer to the press release that was issued today as well.
Pleased to introduce multiple
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |